Advance Agrolife

Why is Advance Agrolife Ltd falling/rising?

As of 30-Aug, Advance Agrolife Ltd's stock price is at Rs 117.00, down 2.74%, reflecting a trend of consecutive declines and reduced investor participation. Despite being net-debt free and reporting significant profit growth, the stock continues to underperform against the benchmark Sensex and its sector.

As of 30-Aug, Advance Agrolife Ltd's stock price is falling, currently at Rs 117.00, which reflects a decrease of Rs 3.3 or 2.74%. The stock has been underperforming compared to the benchmark Sensex, with a performance today that is 0.94% lower than its sector. Over the last two days, the stock has experienced consecutive declines, totaling a drop of 3.68%. <BR><BR>The stock has also touched an intraday low of Rs 116.15, indicating significant selling pressure. Furthermore, there has been a notable decline in investor participation, with delivery volume on 27 August falling by 59.7% compared to the five-day average. This reduced trading activity suggests a lack of confidence among investors.<BR><BR>Despite some positive factors, such as the company being net-debt free and reporting a substantial growth in net profit of 202.28%, these have not been enough to counteract the current downward trend in stock price. The stock's performance over the past week and month has also been negative, with declines of 1.93% and 0.89%, respectively. Overall, the combination of falling investor participation, recent price declines, and underperformance relative to the sector contributes to the current downward movement of Advance Agrolife Ltd's stock price.

Which are the latest news on Advance Agrolife?

What does Advance Agrolife do?

Advance Agrolife Ltd operates in the pesticides and agrochemicals sector, with a market cap of INR 784 Cr, reporting net sales of 330 Cr and a net profit of 23 Cr for June 2026. Key metrics include a P/E ratio of 16.00 and a return on equity of 15.78%.

Overview: <BR>Advance Agrolife Ltd operates in the pesticides and agrochemicals industry and is classified as a micro-cap company.<BR><BR>History: <BR>The incorporation year is not specified, and there are no status changes reported. The latest quarterly results indicate net sales and profit for June 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 330 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 23 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 784 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 16.00 <BR>Industry P/E: 27 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.07 <BR>Return on Equity: 15.78% <BR>Price to Book: 2.45 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: Not available. <BR>Email: Not available. <BR>Website: Not available.

Who are the peers of the Advance Agrolife?

Peers of Advance Agrolife include India Pesticides, Meghmani Organics, Astec Lifesciences, Punjab Chemicals, Dharmaj Crop, Heranba Industries, Best Agrolife, Shivalik Rasayan, and Crop Life Sciences. Management risk varies from excellent to below average among peers, with Meghmani Organics showing the highest 1-year return at -30.58%.

Peers: The peers of Advance Agrolife are India Pesticides, Meghmani Organi., Astec Lifescienc, Punjab Chemicals, Dharmaj Crop, Heranba Inds, Best Agrolife, Shivalik Rasayan, and Crop Life Scienc.<BR><BR>Quality Snapshot: Excellent management risk is observed at India Pesticides and Shivalik Rasayan, while Average management risk is found at Punjab Chemicals, Dharmaj Crop, Heranba Inds, and the rest. Below Average management risk is noted for Meghmani Organi., Astec Lifescienc, and Best Agrolife. Growth is rated as Good for Dharmaj Crop, while Below Average growth is seen at India Pesticides, Meghmani Organi., Astec Lifescienc, Punjab Chemicals, Heranba Inds, and the rest. Capital Structure is rated as Excellent for India Pesticides and Shivalik Rasayan, Good for Punjab Chemicals and Dharmaj Crop, Average for Meghmani Organi., Heranba Inds, and Best Agrolife, and Below Average for Astec Lifescienc and Crop Life Scienc.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Meghmani Organi. at -30.58%, while the peer with the lowest is Heranba Inds at -50.97%. Advance Agrolife's 1-year return is not available for comparison. Additionally, the six-month return is negative for India Pesticides, Astec Lifescienc, Heranba Inds, and Shivalik Rasayan.

How big is Advance Agrolife?

As of 14th August, Advance Agrolife Ltd has a market capitalization of 761.79 Cr and reported net sales of 799.55 Cr and a net profit of 48.90 Cr over the latest four quarters.

As of 14th August, <BR><BR>Market Cap: Advance Agrolife Ltd has a market capitalization of 761.79 Cr, classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 799.55 Cr, while the sum of Net Profit for the same period is 48.90 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the latest annual data is March 2025. Shareholder's Funds are valued at 100.87 Cr, and Total Assets amount to 350.71 Cr.

Should I buy, sell or hold Advance Agrolife Ltd?

When is the next results date for Advance Agrolife Ltd?

The next results date for Advance Agrolife Ltd is August 6, 2026.

The next results date for Advance Agrolife Ltd is scheduled for August 6, 2026.

Are Advance Agrolife Ltd latest results good or bad?

Advance Agrolife Ltd's latest results show strong profit growth, with a 421.68% increase in net profit for Q4 FY26, but revenue has declined sequentially, raising concerns about sustainability. Additionally, cash flow issues and reduced institutional investor participation suggest caution regarding the company's long-term prospects.

Advance Agrolife Ltd's latest results present a mixed picture. On one hand, the company reported a significant increase in net profit for Q4 FY26, reaching ₹7.46 crores, which is up 421.68% year-on-year and 147.90% quarter-on-quarter. This indicates strong profitability improvement and operational efficiency, as reflected in the expansion of the PAT margin to 6.02%, up from 1.59% a year prior.<BR><BR>However, the revenue figures tell a different story. The company recorded revenue of ₹123.88 crores, which represents a robust year-on-year growth of 37.90%. Yet, it also experienced a sequential decline of 6.60% from the previous quarter, highlighting volatility in revenue generation. This inconsistency raises concerns about the sustainability of the recent profit growth.<BR><BR>Additionally, while operating margins improved to 10.80%, the company faces challenges related to cash flow generation, with operating cash flow dropping significantly to ₹5.00 crores from ₹14.00 crores in the prior year. Furthermore, there has been a notable decline in institutional investor participation, which could signal caution among sophisticated investors regarding the company's long-term prospects.<BR><BR>In summary, while the profit growth is commendable, the underlying issues with revenue consistency and cash flow generation, along with declining institutional confidence, suggest that the overall results may not be as favorable as the profit figures alone would indicate. Investors should consider these factors when evaluating the company's performance.